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Abstract
Site-specific proteolysis of proteins plays an important role in many cellular functions and is often key to the virulence of
infectious organisms. Efficient methods for characterization of proteases and their substrates will therefore help us
understand these fundamental processes and thereby hopefully point towards new therapeutic strategies. Here, a novel
whole-cell in vivo method was used to investigate the substrate preference of the sequence specific tobacco etch virus
protease (TEVp). The assay, which utilizes protease-mediated intracellular rescue of genetically encoded short-lived
fluorescent substrate reporters to enhance the fluorescence of the entire cell, allowed subtle differences in the processing
efficiency of closely related substrate peptides to be detected. Quantitative screening of large combinatorial substrate
libraries, through flow cytometry analysis and cell sorting, enabled identification of optimal substrates for TEVp. The
peptide, ENLYFQG, identical to the protease’s natural substrate peptide, emerged as a strong consensus cleavage sequence,
and position P3 (tyrosine, Y) and P1 (glutamine, Q) within the substrate peptide were confirmed as being the most
important specificity determinants. In position P19, glycine (G), serine (S), cysteine (C), alanine (A) and arginine (R) were
among the most prevalent residues observed, all known to generate functional TEVp substrates and largely in line with
other published studies stating that there is a strong preference for short aliphatic residues in this position. Interestingly,
given the complex hydrogen-bonding network that the P6 glutamate (E) is engaged in within the substrate-enzyme
complex, an unexpectedly relaxed residue preference was revealed for this position, which has not been reported earlier.
Thus, in the light of our results, we believe that our assay, besides enabling protease substrate profiling, also may serve as a
highly competitive platform for directed evolution of proteases and their substrates.
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Introduction
Proteases represent one of the largest and most important
protein families known, and their importance in processes that
govern the life and death of a cell cannot be overestimated. The
last decades, it has become evident that proteolysis of bioactive
molecules plays an essential role in the regulation of many
biological processes, such as signal transduction, RNA-transcrip-
tion, apoptosis, and development [1,2]. In addition, proteases are
widely used as virulence factors by many infectious microorgan-
isms, viruses and parasites [3]. Consequently, proteases and their
substrates are therefore of great interest as potential drug targets.
In fact, in humans, proteases represent 5–10% of all drug targets
[4,5].
The function of proteases is regulated either by controlling the
spatial and temporal activity or through their ability to
discriminate among potential substrates, of which the last is
probably the most important mechanism. Accordingly, efficient
methods for characterization of proteases and their associated
substrates could enhance our understanding of biological systems,
which ultimately may result in new therapeutic strategies.
While various biological and chemically based approaches have
been developed to study protease substrate specificity and activity
[6,7] they do have their limitations. Many suffer from being
insensitive, time consuming, labor intensive, result in incomplete
coverage and give no or little information on reaction kinetics.
Among the most popular and powerful recent strategies are those
based on the use of combinatorial substrate libraries. These
libraries can be generated through either biological [8,9,10] or
chemical means [11,12]. Collectively, all these methods have been
of great importance in determining protease function and
specificity. However, innovative high-throughput assays that are
accurate and quantitative are still needed; especially when keeping
in mind that only a small fraction of all human proteases, encoded
by approximately 2% of the human genome, have been studied
[13].
With this in mind, we have developed and used a novel label-
free high-throughput whole-cell method for quantitative analysis
and screening of protease activity in vivo, which is presented herein.
The essential features of this technology are (i) coexpression of
short-lived fluorescent substrates and a protease of interest in the
bacterial cytoplasm, (ii) gain-of-fluorescence in proportion to the
apparent cleavage efficiency, and (iii) monitoring the whole-cell
fluorescence intensity on a flow cytometer.
By applying this methodology, the processing efficiency of
closely related substrate peptides could be analyzed for the highly
specific tobacco etch virus protease (TEVp). Furthermore, we also
adopted this strategy to determine the substrate profile of TEVp
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encoded substrate libraries. Our results suggest that this method-
ology may be generally useful for identification and characteriza-
tion of proteases and their substrate peptides, as well as
development of inhibitors and tailor-made substrates. Importantly,
it will also open up new possibilities for efficient engineering of
proteases towards beneficial properties such as improved activity
and desired specificity.
Results and Discussion
Substrate processing efficiency analyzed by using a novel
fluorescence-assisted whole-cell assay
We have created a convenient, label-free, and function-based
protease assay, suitable for flow cytometry analysis and cell sorting,
by utilizing sensitive short-lived fluorescent substrates expressed in
Escherichia coli (E. coli). To this end, we used plasmid-encoded ssrA-
tagged green fluorescent protein (GFP), containing different
substrate peptides (PS) between the GFP and the ssrA-moiety, as
a quantitative reporter system. The rationale for this was that (i)
the C-terminal ssrA peptide should target the reporter protein,
GFP-PS-ssrA, for rapid degradation by the cytoplasmic ClpXP
proteolytic machinery [14,15,16], unless (ii) coexpression of a
substrate specific protease, from an accessory plasmid, catalyzes
the removal of the ssrA-tag, thus saving the GFP and enhancing
the fluorescence intensity of the entire cell. This can be monitored
on a flow cytometer and desired clones isolated through sorting
(see Figure 1A for the concept). In our study, we used a modified
ssrA-tag (AANDENYNYALAA, ssrA
NY), containing an extra
asparagine (N) and tyrosine (Y) residue (in boldface), since this
has been reported to improve ClpXP-mediated degradation of
ssrA-tagged proteins [17].
The above-described strategy was used to examine the
processing efficiency of the sequence specific tobacco etch virus
protease (TEVp) on three closely related substrate reporters that
only differed in the P19 position (the leaving amino acid) of the
TEVp substrate peptide, ENLYFQX (where X represents glycine,
G; valine, V; or proline, P). The peptides, ENLYFQV (denoted
subV) and ENLYFQP (denoted subP), were included in the
reporter constructs since they should represent substrates cleaved
with low and very low efficiency, respectively, while the natural
substrate peptide, ENLYFQG (denoted subG), is one of the best
TEVp substrates known [18]. As a positive control, we used cells
coexpressing TEVp and GFP-subG (GFP fused to the natural
TEVp substrate but lacking the ssrA-tag). Cells that instead
expressed substrate-less ssrA-tagged GFP (GFP-ssrA
NY) together
with the protease, constituted a negative control.
When the reporter constructs were expressed alone in E. coli, all
but the positive control resulted in very low whole-cell fluorescence
intensities, as expected (data not shown). The fluorescence
intensities were in fact almost identical to the negative control
(Figure 1B). However, when TEVp instead was coexpressed with
the different reporter constructs, the cells started to fluoresce.
Apart from the positive control (GFP-subG), GFP-subG-ssrA
NY
conferred the highest whole-cell fluorescence intensity while GFP-
subV-ssrA
NY and GFP-subP-ssrA
NY exhibited low and very low
fluorescence intensities, respectively (Figure 1B), thus mirroring
the substrate processing efficiency previously reported by Kapust
et al.[18].
Interestingly, in their study, the peptide ENLYFQV performed
relatively well as a substrate (approximately 55% substrate
conversion) when it appeared within a fusion protein subjected
to intracellular processing by TEVp in E. coli cells. However, in
two other assays, in vitro processing of either fusion proteins or
oligopeptides, this peptide proved to be the worst TEVp substrate
of all 20 P19 permutations tested, except ENLYFQP for which no
cleavage could be observed at all [18]. In contrast to our method,
their in vivo assay in general reported much higher cleavage
efficiencies than the corresponding in vitro experiments, especially
for sub-optimal substrates, and was not capable of detecting subtle
differences in catalytic turnover.
We believe that the high catalytic efficiencies they observed in
vivo are probably caused by (i) a relatively high intracellular
concentration of protease and fusion substrate (which usually is
Figure 1. Schematic overview of the fluorescence-assisted whole-cell assay for characterization of proteases. (A) Short-lived
fluorescent reporter substrates (GFP-PS-ssrA) and a protease of interest are coexpressed in E.coli. Protease-mediated removal of the ssrA-tag from the
reporter construct, through in vivo processing of the substrate peptide (PS), rescues GFP from cytoplasmic degradation. This enhances the
fluorescence intensity of the entire cell, thus enabling flow cytometry analysis and cell sorting to collect desired clones. Explanations: GFP, green
fluorescent protein; PS, protease substrate peptide; ssrA, a ClpXP-specific degradation tag. (B) Flow cytometry analysis of E. coli cells that coexpress
TEVp and different reporters constructs, 2.5 h after induction (0.1 mM IPTG, 0.2% arabinose). Three reporter constructs contained closely related TEVp
substrate sequences that only differed in the P19 position. They are represented by the histograms shown in green (DH5a/pMal-TEV2/pGFP-subG-
ssrA
NY; subG=ENLYFQG), purple (DH5a/pMal-TEV2/pGFP-subV-ssrA
NY; subV=ENLYFQV) and blue (DH5a/pMal-TEV2/pGFP-subP-ssrA
NY; subP=EN-
LYFQP). The negative control (DH5a/pMal-TEV2/pGFP-ssrA
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substrates are constantly exposed to each other. This increases the
likelihood of cleavage, and consequently, their in vivo results do not
correctly reflect the catalytic efficiency obtained in solution.
Instead, in our method there is constant competition between the
reactions leading to either elimination or accumulation of the
fluorescent substrate, which ultimately should result in a more
accurate ranking of the substrate processing efficiency, as we see it.
Although GFP-subG-ssrA
NY proved to function very well as a
TEVp substrate in our system, and in fact was the best among the
three ones tested, this particular combination of substrate and
protease variant is not necessarily the best there is. Consequently,
in order to estimate the theoretical dynamic range of our assay,
one must instead use the construct, GFP-subG, which corresponds
to the maximal attainable fluorescence signal in the present system
configuration. Thus, by comparing the whole-cell fluorescence
intensity of the positive control (DH5a/pMal-TEV2/pGFP-
subG), with that of the negative control (DH5a/pMal-TEV2/
pGFP-ssrA
NY), the theoretical dynamic range of our assay
appeared to be around two orders of magnitude (Figure 1B and
Table 1). While GFP-subG-ssrA
NY was cleaved efficiently, it did
not generate as highly fluorescent cells as the positive control did.
Collectively, our results implied that it should be possible to (i)
discriminate among substrates exhibiting different processing
efficiencies and (ii) potentially, also identify peptides that are
cleaved more efficiently than the canonical substrate, ENLYFQG,
if such peptides were to exist.
Combinatorial substrate libraries
Despite TEVp’s popularity as an efficient reagent for removal of
fusion tags from recombinant target proteins [19,20] and in
biomedical research [21,22,23], thorough characterization of its
substrate specificity by applying combinatorial library approaches
have until recently been lacking [24]. Instead, our knowledge of
the substrate specificity has largely been based on alignment and
comparison of naturally occurring processing sites of TEVp as well
as cleavage analysis of substrate variants representing a relatively
limited set of amino acid replacements at relevant positions within
the TEVp substrate consensus sequence, ENLYFQG [25,26].
Thus, only a small number of potential substrate sequences have
been sampled. To close this gap, we constructed three different
genetically encoded combinatorial substrate libraries by using a
PCR-based strategy incorporating NNK degenerate codons at
relevant positions within the substrate encoding sequence. In the
first two libraries, we addressed positions postulated as important
specificity determinants [25,26,27]. More specifically, in library 1,
the positions P6, P3, and P1 were probed (XNLXFXG, Lib1)
while library 2 also included P19 in the randomization process
(XNLXFXX, Lib2). In the non-conserved positions (P5, P4 and
P2) of naturally occurring TEVp substrates, many different amino
acids can be tolerated without total loss of protease processing,
albeit generally at reduced rates [25,26]. In library 3, these
positions including P19 were randomized (EXXYXQX, Lib3).
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7 colony forming units, respective-
ly. Thus, assuming a random distribution, they are expected to
contain all possible ‘‘3-mer’’ and ‘‘4-mer’’ substrate sequences with
.99% confidence limits [28]. DNA sequencing of 192 randomly
picked colonies from each library revealed no particular sequence
bias besides what is imparted by the use of NNK degenerate
codons. Moreover, approximately 10.9%, 12.3% and 11.7% of the
clones in library 1, 2, and 3, respectively, contained amber stop
codons (TAG) due to the applied NNK mutagenesis strategy,
which was very close to the theoretical numbers of 9.1% (library 1)
and 11.9% (library 2 and library 3).
Flow cytometry screening for optimal TEVp substrate
peptides
We then used the fluorescence-assisted whole-cell protease
activity assay in a screening procedure to isolate library members
harboring substrates processed by TEVp and thereby identify its
substrate profile. However, false-positive library members (i.e.,
clones that express reporter peptides lacking the degradation tag,
Table 1. Incidence and in vivo processing efficiency of








ENLYFQG 73 41 501
DNLYFQG 42 23 403
GNLYFQG 13 7 160
YNLYFQG 9 5 152
MNLYFQG 9 5 150
WNLYFQG 7 4 120
CNLYFQG 7 4 165
RNLYFQG 4 2 103
LNLYFQG 426 1
Library 2 XNLXFXX
ENLYFQG 143 80 500
RNLYFQS 14 8 271
ANLYFQG 4 2 313
QNLIFQG 2 1 230
RNLYFQC 2 1 200
Library 3 EXXYXQX
ENLYFQG 121 67 512
ECLYHQG 4 2 311
ERLYVQM 3 2 227
ESEYCQE 2 1 209
EVMYSQA 2 1 178
EFLYIQD 1 ,1 139
ERGYGQV 1 ,1 109
EVWYCQC 1 ,1 107
EVAYGQK 1 ,17 9
ESRYVQS 1 ,16 8
EGEYWQR 1 ,15 7




2.Incidence of a particular clone after screening of library 1, 2 and 3. Data based
on 181, 179 and 182 sequenced clones from library 1, 2 and 3, respectively.
3.Frequency percentage of clonal occurrence.
4.Mean fluorescence intensity (au).
doi:10.1371/journal.pone.0016136.t001
TEVp Substrate Selection
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members where the reporter substrate is processed by an
endogenous protease) had first to be depleted from the library
cultures. This was done in a pre-sorting experiment by expressing
the substrate libraries alone, harvesting non-fluorescent clones
through flow cytometry analysis and cell sorting, re-growing them,
and then repeating the whole procedure once. As can be seen in
Figure 2A, this elimination procedure proved to be very efficient
since virtually all false-positive clones were removed. This was
later also confirmed when we DNA-sequenced the coselected
plasmids from clones that had been isolated in the subsequent
screening for functional TEVp substrates, and only five out of 576
sequenced clones proved to contain an amber stop codon within
the targeted substrate sequence.
Potentially, the pre-screening could remove some sequence
diversity due to endogenous protease activity, and thereby hinder
a true identification of preferred substrates. Although we did not
analyze the exact nature of the sequences removed, it was
comforting to see that the fraction of eliminated cells was close to
the actual incidence of amber stop codon-containing clones in the
different libraries. This indicates that sequences removed due to
the bacteria’s own protease activity is likely to be quite few.
However, to minimize the need for pre-screening, future substrate
libraries should be generated by use of trinucleotide phosphor-
amidites chemistry (trimer codons) [29,30], which eliminates the
risk of introducing stop codons in the substrate encoding sequence.
Off course, false positive clones due to endogenous protease
activity may still arise, but such events can readily be identified
when the individual clones are analyzed with and without the
plasmid encoded protease being expressed. Moreover, should the
number of false positive clones be large, they can be eliminated in
a final sorting round only collecting low-fluorescent cells when the
reporter is expressed alone (i.e., protease expression is not induced).
The pre-sorted libraries were then amplified by growth in liquid
cultures before expression of TEVp and the substrate libraries
were induced, and the fluorescent clones were collected. After two
rounds of sorting, .78% of the enriched clones were highly
fluorescent in all three libraries (Figure 2B). The collected library
members were plated on LB-agar and then subjected to DNA-
sequencing (192 clones from each library), which revealed
substrate peptides identical or with high sequence similarity to
the canonical substrate, ENLYFQG.
Clones enriched from library 1, in which position P6, P3 and P1
had been probed, only exhibited variance in P6, with a strong
preference for the acidic amino acids glutamate (E) and aspartate
(D) in 41% and 23% of the clones, respectively (Table 1). Other
residues that occupied P6 included glycine (G), tyrosine (Y),
methionine (M), tryptophane (W), cysteine (C), and arginine (R) in
7%, 5%, 5%, 4%, 4%, and 2% of the sequenced clones,
respectively (Table 1). Position P6 has been postulated to require
E in functional substrates [25], and this residue is believed to be
involved in an intricate network of hydrogen-bonding interactions
in the crystal structure of the enzyme-substrate complex [27].
Therefore, we were surprised to see the relatively relaxed amino
acid preference that is reported here. However, in P3 and P1
the amino acid composition were in all cases identical to the
wild-type (wt) substrate, namely tyrosine (Y), and glutamine (Q),
respectively, thus emphasizing their great significance as specificity
determinants.
Library 2 also resulted in clones expressing substrate peptides
with a strong resemblance to the canonical TEVp substrate
(Table 1). In fact, after two rounds of sorting, 80% of the clones
proved to have peptide sequences identical to the wt substrate
(Table 1). Interestingly, the second most frequent substrate peptide
(RNLYFQS; 8% of the clones) harbored a positively charged
amino acid, arginine (R), in position P6 (Table 1). This was
unexpected since library 1 resulted in ‘‘winners’’ with a strong
preference for acidic amino acids in that position. However, this
particular peptide contained an additional mutation, namely
serine (S) in P19 that is said to improve the catalytic efficiency (kcat/
KM) by a factor of ,1.5 compared to the wt substrate with glycine
(G) in this position [18]. Thus, this substitution may compensate
somewhat for the negative effect of having arginine in P6. Flow
cytometry analysis of clones expressing either RNLYFQS or
RNLYFQG actually seemed to comply with this, since these
peptides resulted in mean fluorescence intensities (MFI) of 271 and
103 arbitrary units (au), respectively (Figure 3 and Table 1).
In general, like library 1, the functional substrate peptides that
emerged from library 2 exhibited the greatest variation in P6 that
accommodated E, R, G, alanine (A) or glutamine (Q) (Table 1). In
position P19, only G, S or C were detected. This result was to a
large extent consistent with previous studies stating that there is a
strong preference for short aliphatic amino acids (Gly, Ser, Ala,
Met and Cys) in this position [18]. In agreement with the result
from library 1, position P3 (Y) and P1 (Q) proved to be very
important for substrate functionality as they were completely
conserved in all but one peptide in which the tyrosine in P3 was
replaced with isoleucine (I) (Table 1).
Although P5 (N), P4 (L, leucine) and P2 (F, phenylalanine),
should tolerate a large variety of residue substitutions and still
generate a functional substrate [25,26], we observed a very strong
preference for the amino acids found in the canonical substrate.
Approximately 67% of the clones from the sorted library 3 actually
contained the peptide, ENLYFQG, whereas the rest exhibited
Figure 2. Screening of TEVp substrate libraries. Three different
combinatorial substrate libraries were created, using NNK degenerate
codons for randomization of position P6, P3, P1 (Lib1); P6, P3, P1, P19
(Lib2); or P5, P4, P2, P19 (Lib3) within the cognate TEVp substrate
peptide (ENLYFQG). The libraries were then screened for optimal TEVp
substrates. (A) Pre-sorting procedure to eliminate false positive clones
from the libraries: DH5a/pMal-TEV2/pGFP-Lib1-ssrA




pressing the substrate libraries alone (i.e., TEVp expression not induced)
were analyzed on a flow cytometer and non-fluorescent cells were
collected through sorting. Here, the original non-sorted population
from library 2 and the corresponding ‘‘false-positive depleted’’ library
(after two rounds of sorting) are represented by the histograms in
purple and jade, respectively. Library 1 and 3 exhibited the same
appearance as library 2 (data not shown). (B) Enrichment-progress when
screening the libraries for functional TEVp substrates: The false-positive
depleted libraries (see Figure 2A), now coexpressing TEVp and the
substrate libraries, were subjected to quantitative flow cytometry
analysis, and highly fluorescent cells were collected. The populations
from the false-positive depleted library 2, before (jade), after the first
(black) and second round of sorting (green) are shown. All three
libraries had similar appearance (data not shown).
doi:10.1371/journal.pone.0016136.g002
TEVp Substrate Selection
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positions. All enriched clones that were analyzed seemed to
contain functional substrates, but none yielded fluorescence
intensity larger than the wt substrate peptide (Table 1). Interest-
ingly, among the most prevalent residues in P19, besides G, were
A, S and R, which all are amino acids that should generate
functional substrates [18,24,25]. Moreover, when we analyzed
peptides that were identical in all but the normally non-conserved
positions (P5, P4 and P2), they generated different whole-cell
fluorescence intensities. Collectively, the results from the analysis
of library 3, confirmed that P5, P4 and P2 are not critical
specificity determinants but affect the catalytic rate [25,26]. For a
more complete picture of the observed amino acid variability in
the targeted positions of library 3, see Figure S1.
With few exceptions, the incidence of a particular peptide
among the enriched library population correlated relatively well
with its corresponding processing efficiency (Table 1). However,
the peptide RNLYFQS (8%) appeared more often than
ANLYFQG (2%) and QNLIFQG (1%) despite all being processed
with similar efficiency; MFI of 271 au compared to 313 au and
230 au, respectively. Most likely, this deviation is due to sequence
bias in the library. For instance, theoretically, genes encoding
RNLYFQS are 2.25 times and 4.5 times more frequent than genes
coding for ANLYFQG and QNLIFQG, respectively, in library 2.
To our surprise, we did not encounter any clones harboring
substrates better than ENLYFQG. For instance, we anticipated
ENLYFQS to be detected as it is preferred over ENLYFQG, at





21, respectively [18]. However, the amino
acids that flanked the substrate peptides were different in our assay
and in the study by Kapust et al. [18]. In their experiments,
threonine (T) and GTRR, occupied P7 and P29P39P49P59,
respectively, while our reporter constructs instead harbored D
and VDAA in the corresponding positions. This difference may
have affected the substrate processing efficiency in such a way that
ENLYFQS is not necessarily the best TEVp substrate in our
reporter system.
Another conceivable explanation for the absence of this
particular peptide is that it for some reason was not included (or
sampled) in library 2 and 3, although this seems unlikely since they
were large enough to theoretically include all possible gene
sequences with more than 99% probability. Alternatively,
incomplete repression of the TEVp expression during the pre-
sorting procedure may have caused elevated fluorescence intensity
in cells containing highly efficient substrate peptides. Such cells,
potentially including ENLYFQS, would then have been consid-
ered as false-positives and not collected.
Nevertheless, our results suggest that ENLYFQG is the best, or
at least preferred, TEVp substrate. There is also support for this
observation in a very recent study by Boulware et al. [24], where
cell libraries of surface-displayed random peptides were incubated
with exogenous TEVp and screened for TEVp substrates. The
substrates that they identified showed high sequence similarity to
the native substrate, and in fact, seven out of the eight best
peptides harbored G instead of S in P19 [24]. However, we cannot
rule out the possibility that some other peptide sequence can be
processed faster than ENLYFQG.
Characterization of substrate hydrolysis in vivo and in
vitro
The use of protease-mediated rescue of GFP allowed for a
relatively straightforward characterization of the substrate pro-
cessing efficiency. Several individual clones from the sorted
libraries, representing different substrate peptide sequences, were
subjected to flow cytometry analysis in order to rank them on the
basis of their whole-cell fluorescence intensity. The most common
substrate peptides (ENLYFQG and DNLYFQG) from library 1
resulted in MFI of 501 and 403 au, respectively (Figure 3 and
Table 1). The other peptides that were assayed yielded MFI
ranging from approximately 60 to 165 au (Table 1). Individual
clones, isolated from library 2, were analyzed in the same fashion,
and besides the canonical substrate peptide (ENLYFQG), also
RNLYFQS, ANLYFQG, QNLIFQG, and RNLYFQC appeared
to be functional substrates, resulting in MFI of 271, 313, 230, and
200 au, respectively (Figure 3 and Table 1).
Although it is difficult to directly compare quantitative data
obtained through different methods, it has not escaped our notice
that the hierarchical order of the processing efficiency of the
different substrate peptides to a large extent agreed with previous
findings by Dougherty et al [25]. For instance, when they
investigated the preferred amino acid composition in position P6,
the order proved to be E.Q.G.M.A.L, which was the same
as for our whole-cell fluorescence data (Table 1) on substrate
peptides that were similar in both studies. However, in one
instance, when the peptide contained alanine in P6 it performed
better in our assay.
Furthermore, to find out how our hydrolysis data, obtained
through flow cytometry analysis on pure cultures expressing
various reporter substrates, relates to those measured in vitro,w e
analyzed the cleavage kinetics for soluble fusion proteins
containing the corresponding substrate peptides. We reasoned
that this should be a justified analysis since TEVp is frequently
used to remove affinity tags from fusion proteins. A range of
substrates, each composed of ABP-PS-ZZ, were expressed in E. coli
and purified on affinity chromatography columns; PS represents
different TEVp substrate peptides while the albumin binding
protein (ABP) and IgG-binding protein Z, are two highly soluble
affinity tags derived from streptococcal protein G and staphylo-
coccal protein A, respectively [31]. Processing of the various
polypeptide substrates by TEVp was analyzed over time using
polyacrylamide gel electrophoresis (Figure 4A) and the substrate
conversion at each time point was calculated and plotted
(Figure 4B). Cleavage was rapid and close to 100% (98%) efficient
for the fusion protein containing the usual TEVp substrate peptide
(ENLYFQG) over the 6 h incubation time (Figure 4A and 4B). For
the other substrate variants that were tested, processing proved to
be less efficient: 46% (DNLYFQG), 27% (ANLYFQG), 21%
(RNLYFQS), and 18% (RNLYFQG). In addition, determining
Figure 3. Flow cytometry analysis of individual clones that
emerged through screening of library 1 and 2. Each histogram
corresponds to a pure culture of DH5a cells coexpressing TEVp and a
reporter construct containing a unique substrate peptide, 2.5 h after
induction (0.1 mM IPTG, 0.2% arabinose). The different peptides
analyzed are indicated in the figure.
doi:10.1371/journal.pone.0016136.g003
TEVp Substrate Selection
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comparing the effect of the substrate sequence on cleavage;
halftime is the time point, at which 50% of the fusion protein
containing the wt substrate peptide had been processed, in this
particular case approximately 23.5 minutes. At this time point,
only 11%, 7%, 8%, and 6% of the respective substrates had been
processed (Figure 4B).
Although there is not a perfect correlation between data
obtained from the cell-based in vivo fluorescence assay and the in
vitro substrate conversion experiment, importantly, the hierarchical
order of the substrate processing efficiency was identical in either
context.
Conclusions
To summarize, we have presented a novel and powerful method
that allowed us to quantitatively and qualitatively analyze protease
substrate processing in vivo and also rapidly identify the substrate
preference of TEVp. In our search for highly efficient TEVp
substrates, the peptide ENLYFQG, identical to the protease’s
natural substrate peptide, emerged as a strong consensus cleavage
sequence. However, we did not encounter any other peptide that
performed better, although the dynamic range provided by our
system should have allowed for that. This may suggest that this
particular combination of substrate peptide and protease variant
has coevolved to function optimally together. Overall, our findings
were to a large degree consistent with previously reported studies.
For instance, position P3 (Y) and P1 (Q) were almost completely
invariant in all functional substrates, thereby confirming them as
being the most important specificity determinants. Moreover, in
position P19, glycine (G), serine (S), cysteine (C), alanine (A) and
arginine (R) were among the most prevalent residues observed, all
known to generate functional TEVp substrates and in line with
other studies stating that there is a strong preference for short
aliphatic residues in this position. Remarkably, we noticed that a
diverse range of amino acids (E, D, A, R, Q, G, Y, M, W, C, and
L) could be accommodated in P6 and still generate functional
substrates. This came as a surprise since the glutamate that
normally occupies this position is believed to participate in an
intricate hydrogen-bonding network in the protease-substrate
complex [27], and has been postulated as one of the most
important specificity determinants [26,27]. The fact that TEVp
appears to have a larger potential substrate repertoire than
previously known may have impact on its use in biomedical
research and industry, where its popularity is based on its high
sequence specificity and activity.
Although the method proved useful for identification of
substrate peptides, the exact cut position cannot be determined
directly with our assay, as also is the case with many competing
methods for substrate identification. While this might not be an
issue for a well studied protease like TEVp whose substrate profile
is well know, this can be an issue for less-characterized proteases.
One way to determine the scissile bond is through mass
Figure 4. Substrate conversion of different ABP-PS-ZZ fusion proteins by recombinantly produced TEVp. (A) SDS-PAGE analysis
(representative of three independent experiments). ABP-PS-ZZ (10 mg) was incubated with TEVp (0.3 mg) in TEVp reaction buffer at 37uC for different
incubation times (0, 5 min, 15 min, 30 min, 45 min, 60 min, 90 min, 2 h, 3 h, 4 h, 5 h and 6 h). The substrate peptide sequence (PS) in each analyzed
fusion protein is indicated in the figure. As a negative control, we used a fusion protein containing a peptide (SNLVFGP) that cannot be cleaved by
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peptide substrates [32,33]. However, we believe that our system
also is amendable to MS-based identification of the exact cleavage
site. In such a case, the intracellular protein content from bacteria
coexpressing substrate-containing reporters (GFP-PS-ssrA) and
protease would first be released and the cleaved reporter then
affinity captured specifically, before being analyzed by MS (or MS-
MS) to reveal the cleavage position. This approach would thus
eliminate the need for synthetic peptide substrates whose synthesis
can be difficult, costly and time consuming.
Indeed, there are other methods that also utilize or could utilize
competing substrate peptides for screening or selection purposes;
either biological systems such as substrate phage [9], cell displayed
libraries of peptide substrates [10], and protease sensitive genetic
screen based on cyclic AMP signaling cascade in E. coli [34] for
example, or chemical methods based on various synthetic peptide
library formats [35], but none of them operate in the same way as
our system does. For example, unlike most other methods, there is
no need for production and purification of the investigated
protease and/or synthetic substrates, which otherwise can be time
consuming, complicated and expensive. Moreover, besides the
high sensitivity and relatively large dynamic range provided by our
system, it enables direct quantitative measurement of the substrate
conversion and selective enrichment of clones with a desired
processing efficiency. These features should make the presented
method particularly attractive for the engineering of substrate
peptides exhibiting a defined catalytic turnover that could be of
interest in the construction of synthetic and regulatory circuits,
prodrug design, inhibitor discovery, and substrate probe develop-
ment. Finally, our system is unique in that it allows for the
identification of substrate peptides as well as directed evolution of
proteases in such a straightforward way, which is due to the strong
and simple genotype-phenotype link (the protease and substrate
reporter are plasmid-encoded and coexpressed within the analyzed
cells).
Thus, in the light of our results and what has been discussed
here, we believe that our methodology holds great promise as a
highly competitive platform for engineering of proteases and their
substrates, rapid substrate profiling, and protease inhibitor
development, which all are subjects of biological, biomedical and
industrial relevance.
Materials and Methods
Bacterial strains and reagents
E. coli strain RR1DM15 [36] was used as host during
construction of plasmids. E. coli strain DH5a (Gibco) was used
for flow cytometry analysis and cell sorting. E. coli strain Rosetta
(DE3)pLysS (Novagen) was used for production of ABP-PS-ZZ
and TEVp. Culture media and chemicals were from Merck and
Sigma-Aldrich, respectively. DNA modifying enzymes were all
from New England Biolabs and used according to the manufac-
turer’s recommendations. Primers were purchased from MWG
Biotech (for a list of all oligonucleotides used in this study, see
Table S1).
Plasmid constructions
For an overview of the relevant important plasmids constructed
and used in this study, see Figure S2.
To create a TEVp variant suitable for recombinant expression
in E. coli we had the autoproteolysis site inactivated (S219V)
[37,38] and several rare arginine codons exchanged for more
common ones. This was done by combining relevant regions of the
TEVp-encoding vectors pRK693 [39] and pRK793 [37] through
gene splicing by overlap extension [40]. More specifically, two
separate PCR reactions were performed, using the primer pairs
SAPA60/SAPA73, and SAPA72/SAPA61, with pRK693 and
pRK793 as templates, respectively. The two amplicons were then
purified, mixed and used as template in a third PCR reaction, with
primers SAPA60 and SAPA61, to generate the PCR-spliced full-
length product. This product was digested with HindIII as well as
BamHI and ligated into the HindIII/BamHI-digested backbone of
pRK693, yielding pMal-TEV1. TEVp, expressed recombinantly
without any solubility-promoting fusion tag exhibits very poor
solubility in vivo [41,42]. To alleviate this, a sequence encoding the
maltose binding protein (MBP), including a C-terminally attached
TEVp substrate peptide, ENLYFQG, was transferred as a
HindIII/MluI-fragment from pRK793 into the HindIII/MluI-
digested backbone of pMal-TEV1, resulting in pMal-TEV2. Thus,
when TEVp is expressed from pMal-TEV2, the protease will not
be permanently fused to the solubility enhancing MBP-moiety
since this domain is cleaved off in the cell by the protease itself
[41].
Several different TEVp substrate reporter plasmids were
constructed from pGFP-ssrA
NY, which encodes GFP fused to a
modified ssrA-tag (AANDENYNYALAA, ssrA
NY) containing an
extra asparagine and tyrosine residue (in boldface) [17], which
targets the GFP for efficient destruction by the cytoplasmic
degradation complex, ClpXP [15,43]. To this end, GFPmut3 [44]
was PCR-amplified using primers SAPA46 and SAPA47, digested
with SacI and HindIII and then ligated into SacI/HindIII-digested
pBAD33 [45], yielding pGFP-ssrA. From this plasmid we created
pGFP-ssrA
NY by using a QuikChange Site-Directed Mutagenesis
Kit (Stratagene) together with primers GEKO14 and GEKO15.
The primer pairs SAPA62/SAPA63, SAPA65/SAPA65,
SAPA66/SAPA67, and SAPA68/SAPA69 were used to generate
linkers encoding different substrate peptides. The first three,
encoded TEVp substrate variants in which the P19 position of the
wt substrate peptide (ENLYFQG) either accommodated glycine
(G), valine (V) or proline (P), respectively. The last linker encoded
the wt substrate peptide directly followed by a stop codon. All







For production of soluble fusion proteins (ABP-PS-ZZ),
containing different TEVp substrate peptides (PS), plasmid
pABP-PSWT-ZZ was constructed. First, primers zz-for_1 and zz-
rev were employed for amplification of the ZZ gene fragment from
pEZZ-cutinase [46]. The resulting amplicon was used as template
in a second PCR reaction with primers zz-for_2 and zz-rev. The
final PCR product, encoding the TEVp wt cleavage site
(ENLYFQG) fused to ZZ, was gel purified, digested with BamHI
and EcoRI, and ligated into BamHI/EcoRI-digested pAff8c [47],
yielding pABP-PSWT-ZZ. Several pABP-PS-ZZ-variants, encoding
substrate peptides other than the TEVp wt substrate, were also
created by insertion of different relevant oligonucleotide linkers
into BamHI/PstI-digested pABP-PSWT-ZZ.
In order to generate a vector for production of TEVp, a KpnI-
site that should facilitate the replacement of TEVp with other
proteases of interest was first introduced upstream of the TEVp
coding sequence in pMal-TEV2. This was done by PCR
amplification of the plasmid pMal-TEV2 using primers TEV_
mut_fw and TEV_mut_rv. The template plasmid was then
degraded through addition of DpnI. The remaining PCR product
was cleaned using a QiaQuick PCR clean–up kit (Qiagen),
digested with KpnI, and finally recircularized with T4 DNA ligase
to generate pMal-TEV3. The MBP-TEV gene fragment from
plasmid pMal-TEV3 was PCR amplified in two separate PCR
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Mal2 and Mal4. The resulting amplicons were mixed in equimolar
amounts and combined in a hybridization reaction by first raising
the temperature to 95uC followed by slow cooling to room
temperature. After phosphorylation of the hybridized ‘‘sticky end’’
product, it was ligated downstream of the T7 promoter into
BamHI/NcoI-digested pAff8c, resulting in the TEVp production
vector, pTEVprod.
All plasmid constructs were verified by standard DNA
sequencing using Big Dye Terminator 3.1 Cycle Sequencing Kit
and ABI Prisma 3700 sequencer (Applied Biosystems).
Library constructions
Two different combinatorial TEVp substrate libraries, in the
form of XNLXFXG and XNLXFXX, respectively, where X is
any amino acid, were constructed by using a PCR-based strategy.
For construction of library 1, plasmid pGFP-subG-ssrA
NY was
used as template in a PCR reaction with oligonucleotide GEKO19
and the randomized primer GEKOLib1. GEKOLib1 introduced
NNK degenerate codons at positions corresponding to the P6, P3
and P1 residues of the TEVp wt substrate located between the
coding sequences for GFP and ssrA
NY. The amplified gene
fragment was purified by preparative agarose gel electrophoresis,
digested with SalI and DraIII, gel-purified a second time, and then
ligated into SalI/DraIII-digested pGFP-ssrA
NY, resulting in pGFP-
Lib1-ssrA
NY. The library ligation mixture (pGFP-Lib1-ssrA
NY)
was transformed into chemically competent DH5a cells [48] that




were constructed in a similar way. This time, the GEKOLib2
primer was utilized to randomize the TEVp substrate peptide in
positions P6, P3, P1, and P19, while GEKOLib3 instead addressed
P5, P4, P2, and P19. The library sizes were determined by plating
serial dilutions of the transformed cell suspensions on LB agar
plates containing 100 mg/ml ampicillin and 20 mg/ml chloram-
phenicol. All libraries were stored at 280uC as cell suspensions in
LB broth supplemented with glycerol (15% final concentration)
until screened. The library quality, with respect to sequence
variation and frequency of undesired mutations such as nucleotide
deletions and insertions etc, was checked by DNA sequencing of
192 randomly picked clones from each library.
Flow cytometry analysis and library screening
For individual clone analysis and library screening, overnight
cultures of DH5a cells, harboring the TEVp expression vector,





NY; for an overview of other suitable reporter plasmids, see
Figure S1), were subcultured by dilution (1:75 for clone analysis
and 1:150 for the libraries) into fresh LB broth containing 100 mg/
ml ampicillin and 20 mg/ml chloramphenicol, and incubated at
37uC in a rotary shaker set at 150 rpm. When the cultures reached
a cell density of OD600<0.5, IPTG was added to a final
concentration of 0.1 mM to initiate TEVp expression. The
cultures were now placed in a shaker set at 30uC, 150 rpm, and
after 30 minutes, expression of the reporter constructs were
induced by adding L(+)-arabinose to a final concentration of 0.2%.
Two hours later, 1 ml of each culture was placed on ice and 5–
10 ml from each sample was diluted with 1 ml ice-cold 16PBS
(11,68 g NaCl; 9,44 g Na2HPO4; 5,28 g NaH2PO4?2H2O;
1,000 ml MilliQ purified water; pH 7,2) and kept on ice until
analyzed on a FACSVantage SE flow cytometer (Becton
Dickinson). The throughput rate for the analysis was 300
events/sec with 488 nm excitation wavelength (argon ion laser),
emission detection between 510 and 530 nm, and 10,000 events
were recorded for each sample.
Library samples were prepared for fluorescence-activated cell
sorting in essentially the same way as for flow cytometry analysis of
individualclones.Theamountofthawedcells(DH5a/pMal-TEV2/
pGFP-Lib1-ssrA
NY,D H 5 a/pMal-TEV2/pGFP-Lib2-ssrA
NY or
DH5a/pMal-TEV2/pGFP-Lib3-ssrA
NY) used for the overnight
inoculation corresponded to at least tenfold the size of each library.
Rightbeforethelibraryscreening,asmallaliquotofeachculturewas
diluted 100-fold in ice-cold 16PBS. The cells were then analyzed on
a FACSVantage SE flow cytometer with a throughput rate of 250–
400 events/s and sorted according to desired fluorescence intensity
criteria directly into LB media. After sorting, the collected cell
suspensions were either plated on solid LB agar containing the
appropriate antibiotics or re-grown overnight for further rounds of
analysis and cell sorting. More specifically, first we conducted two
initial rounds of sorting that aimed at removing false-positive clones
from the libraries (i.e., cells expressing randomized substrate genes
containing stop codons and frame-shift mutations thereby lacking
the degradation tag, ssrA
NY, or members where the reporter
substrate could be processed by an endogenous protease). This was
accomplishedbycollectingnon-fluorescentcellsfromlibrarycultures
that expressed the substrate reporters alone (only 0.2% arabinose
and no IPTG was added to the cell cultures). The resulting sorted
library population was then amplified by growth in liquid cultures
before expression of both TEVp and reporter substrate was induced.
Highly fluorescent clones, resulting from TEVp-mediated substrate
processing, were collected through sorting. After two rounds, DNA
sequencing of 192 randomly picked colonies from each enriched
library population enabled the identification of functional TEVp
substrate peptides. Clones that either occurred often or exhibited
interesting substrate sequence pattern were selected for further flow
cytometry analysis to score the substrate processing efficiency.
Protein expression and purification
E. coli Rosetta (DE3)pLysS/pTEVprod, was cultured overnight
in a rotary shaker at 30uC, 150 rpm in 500 ml tryptic soy broth
(TSB) supplemented with 50 mg/ml kanamycin and 20 mg/ml
chloramphenicol. Five milliliters of the overnight culture was re-
inoculated in 500 ml fresh TSB medium containing the same
antibiotics and left to grow at 30uC, 150 rpm until OD600 reached
0.5. At that point, TEVp expression was induced by adding IPTG
(0.5 mM final concentration). The cultures were left to grow for
another four hours at 30uC, 150 rpm before the cells were
harvested by centrifugation (2,5006g, 10 min) and resuspended in
60 ml TALON buffer (50 mM NaH2PO4, 300 NaCl, pH 7.5).
Cells lysis was achieved through sonication (4 min, 40% effect) and
the resulting cell debris was removed by centrifugation (30 min,
40,0006g). The soluble protein fraction (supernatant) was loaded
on a 2 ml TALON metal affinity column (Clontech) and treated
according to the manufacturer’s recommendations. For elution of
the immobilized TEVp, the column was washed with 561ml
1.5 M imidazole (pH 7). Notice that although TEVp is originally
expressed as MBP-ENLYFQG-His6-TEVp, the final protease
product will be devoid of the solubility enhancing MBP-moiety
including the majority of the substrate peptide since they are
detached by the protease itself in the cytoplasm. The eluted
fractions, containing the target protein, were pooled, followed by a
buffer exchange into TEVp reaction buffer (100 mM Tris-HCl
(pH 8.0), 25 mM NaCl, 0.5 mM EDTA, 1 mM DTT) using a
PD-10 desalting column (Amersham). The quality of the purified
TEVp was analyzed by sodium dodecyl sulphate-polyacrylamide
gel electrophoresis (SDS-PAGE) and subsequent staining with
GelCode Blue Stain Reagent (Pierce). The protease was then used
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recombinant substrate proteins.
Expression of the different ABP-PS-ZZ protein variants was
performed essentially as described above (where PS represents
alternative TEVp substrate peptides, and ABP is an albumin
binding protein derived from streptococcal protein G, while Z
constitutes an IgG-binding staphylococcal protein A-derivative
[31]. However, the harvested cells (E. coli Rosetta (DE3)pLysS/
pABP-PS-ZZ) were resuspended in 20 ml denaturing lysis buffer
(7 M guanidium chloride, 47 mM Na2HPO4, 2.67 mM
NaH2PO4, 10 mM Tris-HCl, 100 mM NaCl, 20 mM b-mercap-
toethanol, pH 8.0) and incubated for 2h at 37uC. The cell lysate
was centrifuged at 35,3006g for 30 minutes and the supernatant
loaded on an ASPEC XL4 (Gilson) automated protein purification
system equipped with columns filled with 1 mL Talon metal
affinity chromatography resin (Clontech), and purified according
to the protocol described by Steen et al. [49]. The buffer of the
purified protein fractions was exchanged into TEVp reaction
buffer by using PD-10 desalting columns.
In vitro cleavage of different fusion substrates
Enzymatic reactions comprising 10 mg of recombinant ABP-PS-
ZZ fusion proteins (containing different substrate peptides) and
0.3 mg recombinant TEVp in 30 ml TEVp reaction buffer
(100 mM Tris-HCl (pH 8.0), 25 mM NaCl, 0.5 mM EDTA,
1 mM DTT) were incubated at 37uC for different incubation
times (0, 5 min, 15 min, 30 min, 45 min, 60 min, 90 min, 2 h,
3 h, 4 h, 5 h and 6 h). The reactions were terminated by adding
3.3 ml 1% SDS to a final concentration of 0.1%. Before heating at
96uC for 7 min, 10 mlo f3 6SDS denaturing buffer (150 mM
TRIS, 300 mM DTT, 6% SDS, 0.3% bromophenol blue and
30% glycerol) was added to 20 ml of the reactions. After
denaturation, the samples were analyzed on an SDS-PAGE gel
(Novex 4–12% Tris-glycine gradient gel, Invitrogen) and then
stained using GelCode Blue Stain Reagent (Pierce). Finally, the
visualized protein bands were quantified by densitometric means
using Quantity One 1-D Analysis Software (Bio-Rad). All
experiments were executed in three independent replicates.
Supporting Information
Figure S1 Sequence variance of substrate peptides that
emerged from library 3. Sequence logo (http://weblogo.
berkeley.edu/) based on functional substrate sequences that
emerged from the screening of library 3. The dominant sequence
ENLYFQG (approximately 67% of the clones harbored this
peptide) was excluded to be able to reveal the ‘‘residual’’ sequence
variance for the addressed positions (P5, P4, P2 and P19). The
incidence of each amino acid is proportional to the height of the
corresponding letter at that position.
(EPS)
Figure S2 Plasmid chart showing the important vectors
constructed and used in this study.
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